Related Experiment Video
Updated: Jun 11, 2025
05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
1.3K
Alpha-adrenergic antagonists and iris dynamics: Challenges and solutions in cataract surgery
Jaya Kaushik1, Rishi Sharma1, Sumit Goyal2
1Dept of Ophthalmology, Command Hospital (CC), Lucknow, India.
BMC Ophthalmology
|October 4, 2024
Summary
Alpha-1 adrenergic receptor antagonists (α1-ARAs) affect iris parameters, potentially complicating cataract surgery. Awareness of these effects is crucial for physicians and patients.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Alpha-1 adrenergic receptor antagonists (α1-ARAs) are widely used for hypertension and benign prostatic hypertrophy (BPH).
- α1-ARAs, such as Tamsulosin, have been linked to increased surgical risks during cataract surgery.
- This study investigates the impact of α1-ARAs on iris characteristics and cataract surgery challenges.
Purpose of the Study:
- To evaluate the effects of α1-ARAs on iris parameters.
- To assess the correlation between α1-ARAs and operative challenges in cataract surgery.
Main Methods:
- A prospective, cross-sectional study compared 30 patients on α1-ARAs undergoing cataract surgery with 30 matched controls.
- Iris parameters and surgical challenges were evaluated in both groups.
Main Results:
- Patients on α1-ARAs exhibited significantly smaller pupil diameters.
- A notable reduction in iris thickness at the dilator muscle region (DMR) and a lower DMR/SMR ratio were observed in the treated group.
- Longer duration of α1-ARA treatment correlated with a reduced DMR/SMR ratio.
Conclusions:
- α1-ARAs significantly impact pupil size regulation and iris structure, potentially leading to intraoperative floppy iris syndrome (IFIS).
- Tamsulosin demonstrates greater potency in inducing IFIS compared to alfuzosin.
- Ophthalmologists, urologists, and primary care physicians must be aware of these drug-induced effects to mitigate cataract surgery complications.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
403
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
403
01:28Angle Closure Glaucoma: Treatment
448
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
448
01:30Adrenergic Agonists: Therapeutic Uses
743
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
743
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
540
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
540
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
702
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
702
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
558
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
558